Patents Assigned to TIARA PHARMACEUTICALS ,INC.
  • CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION
    Publication number: 20140030323
    Abstract: The present invention provides a controlled-release composition which provides a therapeutically effective plasma concentration of N-acetylcysteine over prolonged period of time. The present invention also includes the use of the controlled-release composition, either alone or in combination with at least one additional active agent, for reduction of vascular inflammation marker and treatment of diseases, conditions, and/or symptoms associated with systemic and/or vascular inflammation in a patient. Furthermore, the present invention provides a process of making granules comprising N-acetylcysteine, or a salt, solvate, prodrug, and/or analog thereof.
    Type: Application
    Filed: July 31, 2013
    Publication date: January 30, 2014
    Applicant: TIARA PHARMACEUTICALS, INC.
    Inventors: Yadon ARAD, Liang C. Dong
  • Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation
    Patent number: 8524772
    Abstract: The present invention provides a controlled-release composition which provides a therapeutically effective plasma concentration of N-acetylcysteine over prolonged period of time. The present invention also includes the use of the controlled-release composition, either alone or in combination with at least one additional active agent, for reduction of vascular inflammation marker and treatment of diseases, conditions, and/or symptoms associated with systemic and/or vascular inflammation in a patient. Furthermore, the present invention provides a process of making granules comprising N-acetylcysteine, or a salt, solvate, prodrug, and/or analog thereof.
    Type: Grant
    Filed: May 11, 2009
    Date of Patent: September 3, 2013
    Assignee: Tiara Pharmaceuticals, Inc.
    Inventors: Yadon Arad, Liang C. Dong
  • CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION
    Publication number: 20110244045
    Abstract: The present invention provides a controlled-release composition which provides a therapeutically effective plasma concentration of N-acetylcysteine over prolonged period of time. The present invention also includes the use of the controlled-release composition, either alone or in combination with at least one additional active agent, for reduction of vascular inflammation marker and treatment of diseases, conditions, and/or symptoms associated with systemic and/or vascular inflammation in a patient. Furthermore, the present invention provides a process of making granules comprising N-acetylcysteine, or a salt, solvate, prodrug, and/or analog thereof.
    Type: Application
    Filed: May 11, 2009
    Publication date: October 6, 2011
    Applicant: TIARA PHARMACEUTICALS ,INC.
    Inventors: Yadon Arad, Liang C. Dong